Fig. 3From: The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancerFlowchart showing the enrollment of TNBC patients and definition of combined immune scores (CIS) used in this study. TNBC, triple-negative breast cancer; TMA, tissue microarray; IHC, immunohistochemistry; TCIS, tumor cells combined immune score; TCIS-L, tumor cells combined immune score-low; TCIS-H, tumor cells combined immune score-high; ICIS, immune cells combined immune score; ICIS-L, immune cells combined immune score-low, ICIS-H, immune cells combined immune score-highBack to article page